StonvexLoading…
StonvexStonvexStonvexCore line items from DOCU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Q4 2025 2025-10-31 | Q3 2025 2025-07-31 | Q2 2025 2025-04-30 |
|---|---|---|---|---|
Revenue | $3.22B | $2.38B | $1.56B | $763.65M |
Operating Income | $298.58M | $210.84M | $125.48M | $60.26M |
Net Income | $309.08M | $218.78M | $135.06M | $72.09M |
EPS (Diluted) | $1.48 | $1.04 | $0.64 | $0.34 |
Total Assets | $4.23B | $3.98B | $3.95B | $3.95B |
Total Liabilities | $2.31B | $2.00B | $1.96B | $1.93B |
Cash & Equivalents | $602.44M | $583.29M | $599.99M | $657.40M |
Free Cash Flow OCF − CapEx | $1.06B | $708.36M | $445.46M | $227.81M |
Shares Outstanding | 197.76M | 200.30M | 201.10M | 202.03M |